Analysts have been eager to weigh in on the Healthcare sector with new ratings on CVS Health (CVS – Research Report), Vertex Pharmaceuticals (VRTX – Research Report) and Veeva Systems (VEEV – Research Report).
CVS Health (CVS)
Bank of America Securities analyst Allen Lutz maintained a Buy rating on CVS Health yesterday and set a price target of $95.00. The company’s shares closed last Monday at $79.56.
According to TipRanks.com, Lutz is a 1-star analyst with an average return of
Currently, the analyst consensus on CVS Health is a Moderate Buy with an average price target of $88.47.
See today’s best-performing stocks on TipRanks >>
Vertex Pharmaceuticals (VRTX)
In a report released yesterday, Mohit Bansal from Wells Fargo maintained a Buy rating on Vertex Pharmaceuticals, with a price target of $540.00. The company’s shares closed last Monday at $420.48.
According to TipRanks.com, Bansal is a 4-star analyst with an average return of
Vertex Pharmaceuticals has an analyst consensus of Moderate Buy, with a price target consensus of $438.25.
Veeva Systems (VEEV)
In a report released yesterday, Bradley Sills from Bank of America Securities maintained a Hold rating on Veeva Systems, with a price target of $240.00. The company’s shares closed last Monday at $230.39, close to its 52-week high of $236.90.
According to TipRanks.com, Sills is a 4-star analyst with an average return of
Currently, the analyst consensus on Veeva Systems is a Moderate Buy with an average price target of $240.26.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on CVS:
